56 related articles for article (PubMed ID: 11366565)
1. Ribavirin for hepatitis C: 80% price reduction available July 9?
James JS
AIDS Treat News; 1999 Jul; (No 322):3-4. PubMed ID: 11366565
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin approved with a big fat price.
Falkenberg J
Notes Undergr; 1998; (No 37):10-1. PubMed ID: 11365818
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C: new treatment overview.
Stoia J
AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
[TBL] [Abstract][Full Text] [Related]
4. Marketing scam spoils hep C treatment.
Proj Inf Perspect; 1998 Dec; (26):6. PubMed ID: 11366498
[TBL] [Abstract][Full Text] [Related]
5. Consensus statement to Schering-Plough Pharmaceuticals from the health care community regarding Rebetron development and marketing.
Notes Undergr; 1999; (No 39):9-13. PubMed ID: 11366786
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C and HIV: ribavirin plus interferon study recruiting.
AIDS Treat News; 1998 May; (No 295):5. PubMed ID: 11365407
[TBL] [Abstract][Full Text] [Related]
7. Anemia during treatment of hepatitis C in HIV-infected patients.
Lo Re V; Kostman JR
AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
[TBL] [Abstract][Full Text] [Related]
8. Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus.
Klein MB; Campeol N; Lalonde RG; Brenner B; Wainberg MA
AIDS; 2003 May; 17(7):1001-8. PubMed ID: 12700449
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
Shakil AO; McGuire B; Crippin J; Teperman L; Demetris AJ; Conjeevaram H; Gish R; Kwo P; Balan V; Wright TL; Brass C; Rakela J
Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
[TBL] [Abstract][Full Text] [Related]
12. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
Yachimski P; Chung RT
AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393
[No Abstract] [Full Text] [Related]
13. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
[TBL] [Abstract][Full Text] [Related]
14. Interferon and ribavirin for hepatitis C.
TreatmentUpdate; 2000 May; 12(3):6-7. PubMed ID: 12125615
[No Abstract] [Full Text] [Related]
15. Interferon-based therapy of hepatitis C.
Chevaliez S; Pawlotsky JM
Adv Drug Deliv Rev; 2007 Oct; 59(12):1222-41. PubMed ID: 17869375
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
[TBL] [Abstract][Full Text] [Related]
17. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin.
Legrand-Abravanel F; Sandres-Sauné K; Barange K; Alric L; Moreau J; Desmorat P; Vinel JP; Izopet J
J Infect Dis; 2004 Apr; 189(8):1397-400. PubMed ID: 15073676
[TBL] [Abstract][Full Text] [Related]
19. Didanosine-ribavirin combination: synergistic combination in vitro, but high potential risk of toxicity in vivo.
Bruno R; Sacchi P; Filice G
AIDS; 2003 Dec; 17(18):2674-5. PubMed ID: 14685062
[No Abstract] [Full Text] [Related]
20. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
